language_icon
EN
HI

Hemant Surgical Industries Share price

HSIL

426.45

20.30 (5.00%)
Last updated on 21 May, 2026 | 14:13 IST
Today's High

426.45

Today's Low

412.00

52 Week Low

89.99

52 Week High

431.25

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Hemant Surgical Industries Chart

Hemant Surgical Industries Share Key Metrics

Volume
80800.00
Market Cap
529.55 CR
LTQ@LTP
400@426.45
ATP
425.78
Var Margin
100 %
Circuit Range
385.85-426.45
Delivery %
43.75 %
Value
3.44 CR
ASM/GSM
No
Market Lot
400

Summary

21 May, 2026 | 14:13 को, Hemant Surgical Industries का शेयर प्राइस आज ₹426.45 पर है, जो दिन के लिए 20.30% की 5.00 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹412.00 और ₹426.45 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹89.99 से ₹431.25 तक रही है। ट्रेडिंग गतिविधि के मामले में, Hemant Surgical Industries ने 80800 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹13038400 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹42578 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 400,42645 रही। यह स्टॉक ₹385.85-426.45 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹3.44 CR है। दिन के लिए डिलीवरी परसेंटेज 43.75% रही। इसके अतिरिक्त, Hemant Surgical Industries वर्तमान में No फ्रेमवर्क के तहत आता है और 400 के मार्केट लॉट साइज़ में ट्रेड करता

Hemant Surgical Industries Fundamentals

View More
P/E Ratio

32.46

P/B Ratio

4.1

Div. Yield

0

Sector P/E

57.53

Sector P/B

2.92

Sec. Div. Yield

0.07

Hemant Surgical Industries Resistance and Support

Pivot 401.13

Resistance

First Resistance

436.26

Second Resistance

466.38

Third Resistance

501.51

Support

First Support

371.01

Second Support

335.88

Third Support

305.76

Hemant Surgical Industries Shareholding Pattern

View More
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

58.9%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.15%

Domestic Institutional Investors

10.73%

Retail

30.21%

Others

0.01%

Total Promoters
MAR '26
58.9%

Hemant Surgical Industries Corporate Actions

DateAgenda
2026-05-15Audited Results

Hemant Surgical Industries News

Hemant Surgical Industries Ltd - 543916 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Singularity Equity Fund I acquired 6,49,600 equity shares of Hemant Surgical Industries Ltd through a preferential allotment on May 15, 2026. This transaction increased the fund's total shareholding from 1.91% to 6.90%.
May 20 2026 10:05:00

Hemant Surgical Industries Ltd - 543916 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Singularity Large Value Fund III increased its shareholding in Hemant Surgical Industries by acquiring 6.49 lakh shares (4.98% stake). The acquisition was through the conversion of convertible warrants, increasing the fund's total holding to 6.90% (8.99 lakh shares) as of May 15, 2026.
May 20 2026 10:05:00

Hemant Surgical Industries Ltd - 543916 - Announcement under Regulation 30 (LODR)-Allotment

Hemant Surgical Industries has allotted 1.5 million equity shares at an issue price of Rs. 197 each. These shares were issued to non-promoter shareholders (Singularity Funds) after the conversion of convertible warrants.
May 15 2026 18:05:00

Hemant Surgical Industries Ltd - 543916 - Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Held On Friday, May 15, 2026

Hemant Surgical Industries reported audited FY26 cons. revenue of ₹231.81 cr (up 117.38% YoY) and net profit of ₹18.19 cr (up 126.24% YoY). The company also successfully raised ₹61.53 cr through equity and warrants, utilizing ₹46.64 cr for strategic growth initiatives.
May 15 2026 16:05:00

Hemant Surgical Industries Ltd - 543916 - Board Meeting Intimation for Audited Standalone And Consolidated Financial Results Of The Company For The Half Year And Financial Year Ended March 31, 2026

Hemant Surgical Industries board will convene on May 15, 2026, to consider and approve the audited financial results for the half year and full financial year ended March 31, 2026. This meeting will finalize the company's financial performance for the period.
May 09 2026 21:05:00
Read More

About Hemant Surgical Industries AboutThe

NSE : 0  
BSE : 543916  
ISIN : INE0GYI01028  

Our Company was originally incorporated as “Hemant Surgical Industries Private Limited” under the provisions of the Companies Act 1956 vide Certificate of Incorporation dated March 27 1989 bearing registration No.051133 issued by Registrar of Companies Maharashtra Mumbai and CIN No. U33110MH1989PTC051133. Subsequently our Company was converted into a public limited company vide special resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 24 1994 and the name of our Company was changed from “Hemant Surgical Industries Private Limited” to “Hemant Surgical Industries Limited” vide fresh Certificate of Incorporation granted to our Company consequent upon conversion into public limited company dated February 22 1994 by the Registrar of Companies Maharashtra Mumbai bearing Corporate Identification Number U33110MH1989PLC051133.Major events and milestones:1989Incorporation of the Company in the name of “Hemant Surgical Private Limted”1993Became the Sole Agent for JMS Co. Ltd Japan for JMS Meditape1994Conversion into Public Limited company with the name Hemant Surgical Industries Ltd.1999Started its first manufacturing plant at Achhad Maharashtra for External Preparation and Small Volume Parentals2018 Entered into exclusive distribution agreement dated July 01 2018 valid for a period of 6 years with JMS Co. Ltd. Japan for importing and marketing JMS Meditape in India. The imported meditape undergoes the process of rewinding slitting and packaging in our assembly unit situated at Atgaon and is then sold in Indian market.2019-Entered into technical collaboration agreement with JMS Singapore Pte. Ltd. for manufacturing Intravenous Infusion Set which are sold under the brand name “JMS” in India.-Signed exclusive distribution agreement with Hemant Phillipines Inc./ Mediply Inc. for supply of renal care equipment medical devices and consumables for marketing the same in entire Phillipines.2021-Appointed as sole agent of SWS Hemodialysis Care Co. Ltd. Chinato sell and do maintenance of SWS4000A hemodialysis machines in West India on exclusive basis.-Entered into MOU with Dr. Venkatesh for setting up of dialysis centre at Guru Harikrishan Hospital 24*7 Dialysis Centre New Delhi2022Achieved a Bench mark of 100 Cr Turnover in the FY 2021-22

Read More

Hemant Surgical Industries Management

NamePosition
Hanskumar Shamji ShahChairman & Managing Director
Kaushik ShahWhole Time Director & Chief Financial Officer
View More

Hemant Surgical Industries FAQs

Hemant Surgical Industries शेयर का खरीद मूल्य 426.45 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Hemant Surgical Industries शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Hemant Surgical Industries शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 32.46 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Hemant Surgical Industries शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 4.1 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Hemant Surgical Industries शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.92 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Hemant Surgical Industries का मार्केट कैप 529.55 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Hemant Surgical Industries शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 431.25 और 89.99 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost